Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s disease and Parkinson’s in a new collaboration which aims to discover ...

Existing drugs could be reused to treat Alzheimer’s and Parkinson’s - Scientists say there are ‘commonalities’ between the ...

AbCellera Biologics' drug candidates in Phase 1 trials show promise, but financial losses and slow progress raise concerns.

Adaptive trials allow for modifications to be made during the trial without requiring additional approvals. According to the ...

Regulatory science also plays a crucial role in ensuring public trust in these products and facilitating the translation of ...

With a $150 million boost in funding, the company aims to integrate advanced AI models with extensive datasets into the drug ...

The Platform Technology Designation, which predates the current FDA leadership, is designed to streamline the drug ...

The MSc in Clinical Drug Development provides students with a multidisciplinary perspective to facilitate their skills. The programme is designed for individuals who need an understanding of drug ...